Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
9 pending office actions • 5 clients • 9 examiners • 8 art units • 0 of 9 (0%) have an AI response strategy ready
COZEN O'CONNOR (Alnylam) is associated with Biotechnology & Pharmaceuticals. It has 9 pending office actions and 19456 career applications, showing a focused active client docket supported by a broad historical application record.
The resolved allowance rate is 85.66%, and the average is 3.35 office actions per allowance. Resolved matters commonly achieve allowance, but the examination process may require multiple responses. For practitioners, the profile supports disciplined monitoring of the active matters while highlighting the need to review biotechnology-specific claim and prior-art issues individually.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §103 only | 3 (33%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 4 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHONG, JASON Y | 1 | 73.3% | +18.1% |
| OLSON, ANDREA STEFFEL | 1 | 62.4% | -11.9% |
| CHO, DAVID H | 1 | 31.9% | +67.0% |
| ZAHORIK, AMANDA MARY | 1 | 58.3% | +49.3% |
| MONTGOMERY, STEPHEN EDWARD | 1 | — | — |
| OGLES, MATTHEW ERIC | 1 | 50.0% | +58.4% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| NGUYEN, KHANH TUAN | 1 | 74.5% | +18.7% |
| TRAN, CHRISTINA L | 1 | 51.6% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18510470 | CORTICAL RECORDING AND SIGNAL PROCESSING METHODS AND DEVICES | OGLES, MATTHEW ERIC | 74d overdue |
| 18259887 | 2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS | BRETZ, COREY LANE | 69d |
| 18897206 | PROCESS AND APPARATUS FOR CHEMICALLY TREATING A CARBON-CONTAINING FEEDSTOCK | CHONG, JASON Y | — |
| 18734491 | METHODS OF TREATING CANCERS OVEREXPRESSING CARM1 WITH EZH2 INHIBITORS AND A PARP INHIBITOR | OLSON, ANDREA STEFFEL | — |
| 18394838 | PROCESSES FOR PRODUCING AND REPROCESSING A RECYCLABLE ETHYLENE-VINYL ESTER POLYMER | MONTGOMERY, STEPHEN EDWARD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18510470 | CORTICAL RECORDING AND SIGNAL PROCESSING METHODS AND DEVICES | OGLES, MATTHEW ERIC | 74d overdue |
| 18897206 | PROCESS AND APPARATUS FOR CHEMICALLY TREATING A CARBON-CONTAINING FEEDSTOCK | CHONG, JASON Y | — |
| 18613537 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | CHO, DAVID H | — |
| 18577377 | BIS-RNAI COMPOUNDS FOR CNS DELIVERY | ZAHORIK, AMANDA MARY | — |
| 18142234 | INORGANIC SOLID PARTICLE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | NGUYEN, KHANH TUAN | — |
| 18015202 | Circular siRNAs | TRAN, CHRISTINA L | — |
| Client (Assignee) | Pending OAs |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 4 |
| Braskem | 2 |
| The Wistar Institut Of Anatomy And Biology | 1 |
| Case Western Reserve University | 1 |
| THOMAS JEFFERSON UNIVERSITY | 1 |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1772 | 1 |
| 1636 | 1 |
| 1765 | 1 |
| 3791 | 1 |
| 1635 | 1 |
| 1761 | 1 |
| 1637 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18897206 | PROCESS AND APPARATUS FOR CHEMICALLY TREATING A CARBON-CONTAINING FEEDSTOCK | Braskem America, Inc. | CHONG, JASON Y | 1772 | §102§103§112 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18734491 | METHODS OF TREATING CANCERS OVEREXPRESSING CARM1 WITH EZH2 INHIBITORS AND A PARP INHIBITOR | The Wistar Institut Of Anatomy And Biology | OLSON, ANDREA STEFFEL | 1693 | §103§112Other | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18613537 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | Alnylam Pharmaceuticals, Inc. | CHO, DAVID H | 1693 | §102§103§112DP | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18577377 | BIS-RNAI COMPOUNDS FOR CNS DELIVERY | Alnylam Pharmaceuticals, Inc. | ZAHORIK, AMANDA MARY | 1636 | §103 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18394838 | PROCESSES FOR PRODUCING AND REPROCESSING A RECYCLABLE ETHYLENE-VINYL ESTER POLYMER | Case Western Reserve University | MONTGOMERY, STEPHEN EDWARD | 1765 | §103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18510470 | CORTICAL RECORDING AND SIGNAL PROCESSING METHODS AND DEVICES | Thomas Jefferson University | OGLES, MATTHEW ERIC | 3791 | §101§112 | Final Rejection | 74d overdue | Pending | Nov 15, 2023 |
| 18259887 | 2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS | Alnylam Pharmaceuticals, Inc. | BRETZ, COREY LANE | 1635 | §103§112 | Final Rejection | 69d | Pending | Jun 29, 2023 |
| 18142234 | INORGANIC SOLID PARTICLE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | Braskem America, Inc. | NGUYEN, KHANH TUAN | 1761 | §103 | Final Rejection | — | Pending | May 02, 2023 |
| 18015202 | Circular siRNAs | Alnylam Pharmaceuticals, Inc. | TRAN, CHRISTINA L | 1637 | §103 | Final Rejection | — | Pending | Jan 09, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial85.7% of resolved applications prosecuted by Cozen O'Connor (Alnylam) were allowed, across 19,456 applications in USPTO records.
3.35 office actions per allowed application on average.
9 pending office actions as of October 2026, for 5 clients, before 9 examiners in 8 art units.
